Locations
North Rhine-Westphalia, Germany · Hilden, Germany
industry
Health · Medical Devices
Size
11-50 employees
founded in
2013
Tripair™ is a novel, minimally invasive tricuspid valve repair technology designed to treat tricuspid regurgitation — a condition that affects millions globally, with the vast majority currently remaining untreated. Tripair™ simplifies tricuspid valve repair through an innovative transcatheter edge-to-spacer approach. By overcoming the key challenges of procedural complexity and limited adoption, we are on a mission to make TR treatment as simple as a right heart catheterization — so it can be performed by any interventionalist, anywhere. Tripair™ is developed by Coramaze Technologies, a pre-commercial stage company with offices in Germany and Israel. The technology is currently investigational and not yet available for commercial use.
Something looks off?On-site & Remote